http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111943911-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
filingDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111943911-B |
titleOfInvention | Acrylamido benzazepine derivatives as GSK-3β inhibitors and uses thereof |
abstract | The invention belongs to the technical field of medicinal chemistry and discloses an acrylamido benzazepine as a glycogen synthase kinase-3β (GSK-3β) inhibitor Derivatives and their uses. The acrylamido benzazepine as GSK-3β inhibitor The derivatives are compounds represented by formula (I) or pharmaceutically acceptable salts thereof. The compound has good inhibitory activity on GSK-3β, and can be used as a selective inhibitor to prevent and treat diseases related to GSK-3β, and the diseases related to GSK-3β include cancer, neurodegenerative diseases and diabetes. |
priorityDate | 2019-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 467.